HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marthandan Mahalingam Selected Research

Plague Vaccine

10/2018A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague.
1/2017A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marthandan Mahalingam Research Topics

Disease

4Plague (Bubonic Plague)
01/2019 - 01/2013
3Infections
04/2024 - 10/2018
2Communicable Diseases (Infectious Diseases)
01/2019 - 01/2019
2Anthrax
10/2018 - 01/2017
1Virus Diseases (Viral Diseases)
08/2015
1Neoplasms (Cancer)
10/2008

Drug/Important Bio-Agent (IBA)

5VaccinesIBA
04/2024 - 01/2013
3Proteins (Proteins, Gene)FDA Link
04/2024 - 10/2008
2Plague VaccineIBA
10/2018 - 01/2017
2Subunit VaccinesIBA
10/2018 - 01/2016
1Complex MixturesIBA
04/2024
1OmpC proteinIBA
12/2019
1LipopolysaccharidesIBA
12/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1Biological Warfare AgentsIBA
10/2018
1AntigensIBA
10/2018
1Combined VaccinesIBA
10/2018
1NanovaccinesIBA
10/2018
1Capsid Proteins (Capsid Protein)IBA
10/2018
1BiothraxIBA
10/2018
1Synthetic Vaccines (Recombinant Vaccines)IBA
08/2015
1Blocking AntibodiesIBA
08/2015
1Aluminum Hydroxide (Algeldrate)FDA Link
01/2013
1Codon (Codons)IBA
10/2008
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2008

Therapy/Procedure

2Therapeutics
04/2024 - 01/2019